Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (less than 91 Days) With Suspected or Complicated Intra-Abdominal Infections

Next Previous
Trial Profile

Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (less than 91 Days) With Suspected or Complicated Intra-Abdominal Infections

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Apr 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Meropenem (Primary)
  • Indications Acute enterocolitis; Bacterial infections; Intra-abdominal infections; Necrotising enterocolitis
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms Meropenem PK

    • Most Recent Events

    • 28 Nov 2011 Primary endoints added as reported by ClinicalTrials.gov.
    • 14 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 May 2010 Actual patient number (200) added as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top